| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/23/2009 | CN101537154A Manufacturing method of medicament for treating ten kinds of diseases |
| 09/23/2009 | CN101537153A Chinese traditional medicine preparation for curing breast cancer |
| 09/23/2009 | CN101537146A Chinese medicine for treating carcinoma of colon |
| 09/23/2009 | CN101537144A Chinese material medical preparation for treating esophagus cancer and gastric cancer of digestive system |
| 09/23/2009 | CN101537125A Chinese medicine for treating uterine cancer |
| 09/23/2009 | CN101537113A Chinese traditional medicine preparation for curing thyroid tumor |
| 09/23/2009 | CN101537101A Drug used for curing liver, limb muscles and pelvic blood vessel tumors and complicating diseases thereof, varicosity of leg and ulcer with hemorrhage and a preparation method thereof |
| 09/23/2009 | CN101537081A Matsutake health-care medicinal liquor with anticancer function and human body immunizing power enhancement function |
| 09/23/2009 | CN101537066A Chinese herbal medicine for treating tumor |
| 09/23/2009 | CN101537061A Chinese medicine for treating liver cancer |
| 09/23/2009 | CN101537057A Traditional Chinese medicine composition for treating cancer and cocktail therapy thereof |
| 09/23/2009 | CN101537042A Applied medicament for treating breast neoplasms |
| 09/23/2009 | CN101537036A Soap pod saponin extract as well as preparation method and application thereof |
| 09/23/2009 | CN101537027A Extract with anti-lung cancer activity of streptocaulon juventas (Loureiro) Merrill and preparation process of compounds thereof |
| 09/23/2009 | CN101537025A Preparation method for increasing content of total saponin, low polarity saponin and argininyl fructosy glucose in red ginseng |
| 09/23/2009 | CN101537024A Method for preparing active anticancer fractions through conversion of total ginsenosides in panax plants by strain of fusarium sacchari |
| 09/23/2009 | CN101537023A Medicine for treating cancer |
| 09/23/2009 | CN101537015A Application of carbon nano-tubes in immunity accelerators for preparing anti-tumor immunotherapy medicaments |
| 09/23/2009 | CN101537014A Anti-tumor arsenic combined drug |
| 09/23/2009 | CN101537013A Application of nanometer polysaccharide for preparing antineoplastic medicament |
| 09/23/2009 | CN101537007A Application of N-(thiofuran-2) pyrazolo (1, 5-a) pyridine-3-formanides compounds for preparing antineoplastic |
| 09/23/2009 | CN101537006A Application of pyridazinone compounds in preparing antitumor drugs |
| 09/23/2009 | CN101537001A Application of compound as JAK-STAT3 signal passage inhibitor |
| 09/23/2009 | CN101536993A Vitamin D3 microcapsule and preparation method thereof |
| 09/23/2009 | CN101536990A Colchicines gastric floating sustained-release tablet and method for preparing same |
| 09/23/2009 | CN101536987A Sodium alginate microballoon vein suppository containing hemangioma-resisting medicant, preparation method and application thereof |
| 09/23/2009 | CN101536986A Sodium alginate targeted sustained release microsphere vascular occlusive agent containing Sorafenib as well as preparation and application thereof |
| 09/23/2009 | CN101536984A Injection-use recombinant human Endostatin porous sustained-release microsphere and preparation method thereof |
| 09/23/2009 | CN101536982A Trastuzumab-modified toxin protein-coated PEG immune liposome and preparation and application thereof |
| 09/23/2009 | CN101536980A Rubescensin preparation and preparation method and use of same |
| 09/23/2009 | CN101536968A Cellular fluid of fresh flowers of roses and preparation method thereof |
| 09/23/2009 | CN100543016C Intermediate compound of 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives |
| 09/23/2009 | CN100542612C Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 09/23/2009 | CN100542606C Vaccine composition comprising tumour antigen and adjuvant composition |
| 09/22/2009 | US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592449 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 09/22/2009 | US7592437 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/22/2009 | US7592430 Monoclonal antibody specific to macrophage colony stimulating factor (M-CSF) for use in treatment and prevention of infection, inflammation, nervous system, respiratory system, bone and skin disorders |
| 09/22/2009 | US7592356 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 09/22/2009 | US7592349 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors |
| 09/22/2009 | US7592340 Quinoxalines useful as inhibitors of protein kinases |
| 09/22/2009 | US7592339 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/22/2009 | US7592323 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 09/22/2009 | US7592309 Method of using a peptide having analgesic and antitumor activity from scorpion |
| 09/22/2009 | US7592149 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 09/22/2009 | US7592140 2′, 5′-oligoadenylate phosphodiesterase |
| 09/22/2009 | US7592012 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
| 09/22/2009 | US7592010 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 09/22/2009 | US7592005 Multiple myeloma; targeting antibody conjugated with a radionuclide or other cytotoxic substance |
| 09/22/2009 | US7591995 Cobalamin conjugates useful as imaging and therapeutic agents |
| 09/22/2009 | CA2419588C Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 09/22/2009 | CA2402121C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 09/22/2009 | CA2360419C Molecules for the treatment and diagnosis of tumours |
| 09/22/2009 | CA2353604C Polymeric coatings for controlled delivery of active agents |
| 09/17/2009 | WO2009114856A2 Aurora kinase inhibitors |
| 09/17/2009 | WO2009114831A2 Process to produce fibrillar proteins and method of treating using fibrillar proteins |
| 09/17/2009 | WO2009114826A2 Treatment systems and methods for renal-related diseases |
| 09/17/2009 | WO2009114816A2 Therapeutic cancer antigens |
| 09/17/2009 | WO2009114809A1 Therapies for cancer using isotopically substituted lysine |
| 09/17/2009 | WO2009114658A2 Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancer |
| 09/17/2009 | WO2009114623A2 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 09/17/2009 | WO2009114585A1 Anti-tyrp1 antibodies |
| 09/17/2009 | WO2009114512A1 Azetidine and cyclobutane derivatives as jak inhibitors |
| 09/17/2009 | WO2009114462A2 Local delivery of chemotherapeutic agents to skeletal metastases |
| 09/17/2009 | WO2009114126A1 Piperlongumine and piperlongumine analogs for use in the treatment of cancer |
| 09/17/2009 | WO2009114110A1 Engineered fusion molecules immunotherapy in cancer and inflammatory diseases |
| 09/17/2009 | WO2009113965A1 Isthmin derivatives for use in treating angiogenesis |
| 09/17/2009 | WO2009113902A1 Antitumoral terpenoid pharmaceutical composition 'abisilin' exhibiting angiogenesis-inhibiting action |
| 09/17/2009 | WO2009113743A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 09/17/2009 | WO2009113579A1 Double-stranded nucleic acid molecule suitable for prevention or treatment of cancer, cancer cell proliferation inhibitor, and pharmaceutical preparation |
| 09/17/2009 | WO2009113560A1 Fused heterocyclic compound |
| 09/17/2009 | WO2009113495A1 Liver cancer detection method using gene capable of being expressed in liver cancer-specific manner, and therapeutic and prophylactic agent for liver cancer |
| 09/17/2009 | WO2009113436A1 Method for enhancing the anti-cancer activity of radioactive ray by using fgf33 gene inhibitor in combination with irradiation with the radioactive ray, and method for reducing adverse side effects of radioactive ray |
| 09/17/2009 | WO2009113423A1 Bicyclic pyrrole compound |
| 09/17/2009 | WO2009113320A1 Mmp inhibitor |
| 09/17/2009 | WO2009113295A1 C2orf18 as target gene for cancer therapy and diagnosis |
| 09/17/2009 | WO2009113109A1 New phenanthrylphenol linked pyrrolo[2,l-c][l,4]benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof |
| 09/17/2009 | WO2009113085A1 Novel benzimidazole linked pyrrolo[2,1-q[1,4] benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof |
| 09/17/2009 | WO2009113084A1 C2-fluoro substituted piperazine linked pyrrolo[2,1-c][1,4] benzodiazepine dimers and a process for the preparation thereof |
| 09/17/2009 | WO2009112652A1 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112651A1 Imidazo[1,2-a]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 09/17/2009 | WO2009112615A1 Pharmaceutical composition for inhibiting the transcription factor inducible by hypoxia, modulators of pathological processes of angiogenesis, oncogenesis, inflammation, apoptosis, and cellular therapy |
| 09/17/2009 | WO2009112565A1 Thiazolyl-dihydro-indazoles |
| 09/17/2009 | WO2009112550A1 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds |
| 09/17/2009 | WO2009112529A1 Novel method for the production of sulphonylpyrroles as hdac inhibitors |
| 09/17/2009 | WO2009112524A1 Pyridopyrimidines as plk1 ( polo-like kinase) inhibitors |
| 09/17/2009 | WO2009112522A1 (E)-N-(2-Amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide salts |
| 09/17/2009 | WO2009112473A1 Novel compounds |
| 09/17/2009 | WO2009112439A1 4-aryl-2-anilino-pyrimidines as plk kinase inhibitors |
| 09/17/2009 | WO2009112266A1 Active substance combination with gemcitabine for the treatment of epithelial cancer |
| 09/17/2009 | WO2009112245A1 Antibody against the csf-1 r |
| 09/17/2009 | WO2009112022A2 Pharmaceutical composition for the diagnosis or treatment of diseases associated with zinc finger proteins |
| 09/17/2009 | WO2009112021A2 Pharmaceutical composition for the diagnosis or treatment of a plasmocytoma |
| 09/17/2009 | WO2009111948A1 The salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione or its derivatives, their polymorphs, preparation methods and uses thereof |
| 09/17/2009 | WO2009111892A1 Microrna mediated oncolytic targeting |
| 09/17/2009 | WO2009111868A1 Method of treating cancer using a neuropeptide y 5r (np y5r) antagonist |
| 09/17/2009 | WO2009111846A1 Mitochondrially delivered anti-cancer compounds |
| 09/17/2009 | WO2009092892A3 Novel composition for treating the side effects of anticancer treatments |
| 09/17/2009 | WO2009089338A3 Method and compositions for administering resveratrol and pterostilbene |